CClinicalTrials.gg
CompletedNCT06378723Updated Feb 3, 2026

The Relationship Between Upper Extremity Functionality, Trunk Control and Balance in Children With Cerebral Palsy

An observational study in Cerebral Palsy, Diplegic Cerebral Palsy and Balance; Distorted, sponsored by Eastern Mediterranean University. Completed at 2 sites in 2 countries. Open to participants aged 8 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-03.

Sponsored by Eastern Mediterranean University · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
53
Ages
8 Years to 18 Years
Sex
All
01

Study summary

The aim of this study is to examine the relationship between trunk control, upper extremity functionality and balance in children with cerebral palsy and to compare this relationship with healthy sedentary children.This study is carried out through Eastern Mediterranean University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Pediatric Rehabilitation Unit.

Read the detailed description

23 children with Cerebral Palsy and 30 healthy children will be included in the study, and the families of all children participating in the study will sign an informed consent form.After signing the consent form from the families of the children included in the study, their demographic information will be recorded and their Gross Motor Function Classification System levels will be determined.

Children's upper extremity functionality will be evaluated with the Quality of Upper Extremity Skills Test. To determine their functional balance, the Single-Leg Stance Test and the Four Step Square Test are measured. Additionally, balances will be determined by the Trunk Control Measurement Scale. Evaluations are made using tables and chairs. Evaluations take approximately 60 minutes, depending on the condition of the children, and all evaluations will be made one-on-one by the physiotherapist. In the study where power analysis was performed, 50 child evaluations were deemed appropriate. Statistical Package for the Social Sciences package program is used to analyze the data. Whether the data complies with normal distribution will be evaluated using the Shapiro Wilk Test and histogram graphs. Descriptive statistics are given as mean, standard deviation, median, number and percentage. Numerical data between groups are compared using Student's t test and Mann Whitney U test. Categorical data will be compared using the Chi Square test. Spearman's correlation test was used for correlation analysis, p value \<0.05 will be considered statistically significant.

02

Conditions studied

  • Cerebral Palsy
  • Diplegic Cerebral Palsy
  • Balance; Distorted

Browse trials for

Keywords

  • cerebral palsy
  • upper extremity
  • trunk control
  • functionality
  • balance
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 53 is below the median of 63 across 455 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Eastern Mediterranean University is the lead sponsor of 136 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Cerebral Palsy and healthy children between the ages of 8 and 18 will be included in the study. Children with hearing and vision loss will be excluded from the study in order not to affect balance disorders. In order to standardize their mobility, those with GMFC levels 1 and 2 will be included in the study.

Inclusion criteria

  • Between the ages of 8-18,
  • Gross Motor Function Classification System level 1-2,
  • Do not have severe visual or hearing impairment,
  • Does not have any cooperation problems that would hinder communication,
  • Children who have had Botulinum Toxin-A injection

Exclusion criteria

Exclusion Criteria:

  • Those with GMFC level 3-4-5,
  • Children who had surgery within the last six months were not included in the study.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
53 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Healthy Children

    Healthy children between the ages of 8 and 18 will be included in the study. Children with hearing and vision loss will be excluded from the study in order not to affect balance disorders.

    Other: Balance Tests

  • Cerebral Palsy Children

    Cerebral Palsy children between the ages of 8 and 18 will be included in the study. Children with hearing and vision loss will be excluded from the study in order not to affect balance disorders. In order to standardize their mobility, those with Gross Motor Function Classification levels 1 and 2 will be included in the study.

    Other: Balance Tests

Interventions

  • OtherBalance Tests

    With the scales and tests the children trunk control, quality of upper extremity skills, single leg stance duration will be measured

06

What researchers measure

Primary outcomes

  1. trunk control

    All the children will be measured with the Trunk Control Measurement Scale. This test includes 15 items that measure static and dynamic sitting balance, two components of trunk control during functional activities. All items are scored on 2, 3 or 4 points and are administered bilaterally. The total score is between 0-58. A high score indicates good performance.

    Time frame: one month

  2. upper extremity functionality

    All the children will be measured with the Quality of upper extremity skills test. This test evaluates the quality of upper extremity movements; It evaluates in 4 different areas: independent movements, grasping, weight bearing and protective extension. In protective extension, falling to the front, back and side using the arms is evaluated. A "yes" or "no" score is given depending on the completion of each action or task. Scores in these four areas are added together for a total score. Additionally, hand function, spasticity and cooperation are also evaluated. In hand function evaluation, 0 to 10 points are marked for the right hand, left hand and bilaterally. In cooperation, children's cooperation statuses are marked as "not cooperative", "partially cooperative" and "fully cooperative". During the evaluation, the child is not allowed to use any devices for the upper extremity. Both the child's right and left upper extremities are scored separately. Total score is between 0 and 100.

    Time frame: one month

  3. balance

    all the children will be measured with the Four Step Square Test and Single leg Stance test. It is desirable to maintain this posture for as long as possible during the test. The test and duration begin with the foot being lifted off the ground. The test is repeated twice and the best time measured is noted in seconds (for single leg stance). The test begins with one foot of the individual touching the ground in the 2nd square and ends with the last foot touching the ground in the 1st square. The test is repeated twice for each individual and the test score completed in the shortest time is recorded in seconds (four step square test).

    Time frame: one month

  4. Weight and Height

    Weight and height will be combined to report BMI in kg/m2

    Time frame: one month

07

Study locations

2 sites
  • Eastern Mediterranean University
    Famagusta, 99628, Cyprus
  • Yeni Sihirli Eller Özel Eğitim ve Rehabilitasyon Merkezi
    Adana, Çukurova 01170, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06378723
Lead sponsor
Eastern Mediterranean University
Responsible party
Burçin Uğur Tosun (Principal Investigator PhD Physiotherapist Burcin Ugur Tosun, Eastern Mediterranean University) — Principal investigator
First posted
Apr 22, 2024
Start date
Feb 1, 2024
Primary completion
Apr 15, 2024
Completion
Apr 16, 2024
Last update
Feb 3, 2026

Study contacts

Emine Tuzun, Prof
study director · Eastern Mediterranean University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion